Evidence map›Paper›PMID 38168672›Full record

ArticleJournal of virology2024

Virology-the path forward.

Angela L Rasmussen, Gigi K Gronvall, Anice C Lowen, Felicia Goodrum, James Alwine, Kristian G Andersen, Simon J Anthony, Joel Baines, Arinjay Banerjee, Andrew J Broadbent and 68 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Principal Investigator Responsibility for Flagging Research with Dual-Use or Pandemic Risk.Applied biosafety : journal of the American Biological Safety Association · 2025
    Article
  3. Reply to Masters: Recombinant coronavirus balances biosafety and benefit.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Public role in research oversight.Journal of virology · 2024
    Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

78 authors at 20 institutions in 2 countries.

Angela L RasmussenVaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada.ORCID 0000-0001-9462-3169
Gigi K GronvallDepartment of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0003-2514-146X
Anice C LowenDepartment of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-9829-112X
Felicia GoodrumDepartment of Immunobiology, University of Arizona, Tucson, Arizona, USA.ORCID 0000-0002-6646-7290
James AlwineDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kristian G AndersenDepartment of Immunology and Microbiology, Scripps Research, La Jolla, California, USA.
Simon J AnthonyDepartment of Pathology, Microbiology, and Immunology, University of California, Davis, Davis, California, USA.
Joel BainesDepartment of Microbiology and Immunology, Cornell University, Ithaca, New York, USA.ORCID 0000-0002-6397-2830
Arinjay BanerjeeVaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada.ORCID 0000-0002-2821-8357
Andrew J BroadbentDepartment of Animal and Avian Sciences, University of Maryland, College Park, Maryland, USA.ORCID 0000-0002-4716-1835
Christopher B BrookeDepartment of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.ORCID 0000-0002-6815-1193
Samuel K CamposDepartment of Immunobiology, University of Arizona, Tucson, Arizona, USA.ORCID 0000-0003-1540-9821
Patrizia CaposioVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.ORCID 0000-0001-7579-849X
Arturo CasadevallDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-9402-9167
Gary C ChanDepartment of Microbiology and Immunology, SUNY Upstate Medical Center, Syracuse, New York, USA.ORCID 0000-0001-8209-9777
Anna R CliffeDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0003-1136-5171
Donna Collins-McMillenDepartment of Immunobiology, University of Arizona, Tucson, Arizona, USA.
Nancy ConnellDepartment of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Blossom DamaniaDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-9205-1774
Matthew D DaughertyDepartment of Molecular Biology, University of California, San Diego, La Jolla, California, USA.
Kari DebbinkDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Terence S DermodyDepartment of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-1853-8741
Daniel DiMaioDepartment of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-2060-5977
W Paul DuprexCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-1716-6376
Michael EmermanHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Denise A GallowayHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Robert F GarryDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Stephen A GoldsteinDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Alexander L GreningerDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-7443-0527
Amy L HartmanDepartment of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-0857-2973
Brenda G HogueSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Stacy M HornerDepartment of Integrative Immunobiology, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-9351-7409
Peter J HotezDepartment of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA.
Jae U JungDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0003-4559-8774
Jeremy P KamilDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.ORCID 0000-0001-8422-7656
Stephanie M KarstDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, USA.
Lou LaiminsDepartment of Microbiology, Ohio State University, Wooster, Ohio, USA.ORCID 0000-0002-6314-623X
Seema S LakdawalaDepartment of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-7679-2150
Igor LandaisVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Michael LetkoPaul G. Allen School for Global Health, Washington State University, Pullman, Washington, USA.ORCID 0000-0002-7640-2861
Brett LindenbachDepartment of Microbial Pathogenesis, Yale University, New Haven, USA.
Shan-Lu LiuDepartment of Microbiology, Ohio State University, Wooster, Ohio, USA.ORCID 0000-0003-1620-3817
Micah LuftigDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-2964-1907
Grant McFaddenSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-2556-3526
Andrew MehleDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0001-6060-4330
Juliet MorrisonDepartment of Microbiology and Plant Pathology, University of California, Riverside, Riverside, California, USA.
Anne MosconaDepartment of Microbiology and Immunology, Columbia University, New York, New York, USA.ORCID 0000-0002-1796-8320
Elke MühlbergerDepartment of Virology, Immunology, and Microbiology, Boston University, Boston, Massachusetts, USA.
Joshua MungerDepartment of Biochemistry and Biophysics, University of Rochester, Rochester, New York, USA.ORCID 0000-0001-5379-9440
Karl MüngerDepartment of Developmental, Molecular, and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Eain MurphyDepartment of Microbiology and Immunology, SUNY Upstate Medical Center, Syracuse, New York, USA.ORCID 0000-0003-3449-5024
Christopher J NeufeldtDepartment of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.
Janko Z NikolichDepartment of Immunobiology, University of Arizona, Tucson, Arizona, USA.
Christine M O'ConnorDepartment of Infection Biology, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0003-4943-3774
Andrew PekoszDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0003-3248-1761
Sallie R PermarDepartment of Pediatrics, Weill Cornell Medicine, New York, New York, USA.ORCID 0000-0003-1438-4554
Julie K PfeifferDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0003-2973-4895
Saskia V PopescuDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
John G PurdyDepartment of Immunobiology, University of Arizona, Tucson, Arizona, USA.ORCID 0000-0001-7460-7567
Vincent R RacanielloDepartment of Microbiology and Immunology, Columbia University, New York, New York, USA.
Charles M RiceLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, USA.
Jonathan A RunstadlerDepartment of Infectious Disease and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA.ORCID 0000-0002-6747-7765
Martin J SappDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.ORCID 0000-0003-3916-8890
Rona S ScottDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.ORCID 0000-0003-3840-9189
Gregory A SmithDepartment of Microbiology, Ohio State University, Wooster, Ohio, USA.ORCID 0000-0001-9644-8472
Erin M SorrellDepartment of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Emily SperanzaFlorida Research and Innovation Center, Cleveland Clinic Lerner Research Institute, Port St. Lucie, Florida, USA.
Daniel StreblowVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Scott A TibbettsDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, USA.ORCID 0000-0001-8889-1642
Zsolt TothDepartment of Oral Biology, University of Florida, Gainesville, Florida, USA.ORCID 0000-0001-6628-3945
Koenraad Van DoorslaerDepartment of Immunobiology, University of Arizona, Tucson, Arizona, USA.
Susan R WeissDepartment of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-8155-4528
Elizabeth A WhiteDepartment of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-7378-7690
Timothy M WhiteDepartment of Immunobiology, University of Arizona, Tucson, Arizona, USA.
Christiane E WobusDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0001-5286-0924
Michael WorobeyDepartment of Ecology and Evolutionary Biology, University of Arizona, Tucson, Arizona, USA.
Satoko YamaokaDepartment of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Andrew YurochkoDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.ORCID 0000-0002-6452-5813
University of Arizona · USJohns Hopkins University · USLouisiana State University Health Sciences Center Shreveport · USEmory University · USOregon Health & Science University · USUniversity of Florida · USUniversity of Pennsylvania · USUniversity of Pittsburgh · USArizona State University · USCleveland Clinic · USColumbia University · USCornell University · USDuke University · USFred Hutch Cancer Center · USSUNY Upstate Medical University · USTufts University · USUniversity of Saskatchewan · CAYale University · USBaylor College of Medicine · USBoston University · US

Funding

Project 4-Tracking cytomegalovirus-primed long-lived NK cells in salivary glandP20GM134974 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ANDREW D YUROCHKO · 2021 to 2026
$15.0M
Practices CoreUC7AI180311 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI William Paul Duprex · 2023 to 2026
$13.2M
Pathogen-driven evolution of innate antiviral defense mechanismsR35GM133633 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Matthew Daugherty · 2019 to 2026
$3.3M
UC San Diego RAPID Faculty Development Program in Infectious DiseasesR25AI147376 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADRIANA H TREMOULET, Joann Trejo · 2020 to 2026
$2.5M
NIAID NIH HHS R25 AI147376NIAID NIH HHS UC7 AI180311NIGMS NIH HHS R35 GM133633
6 · The paper itself

Abstract

In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.

Indexed as

Biomedical ResearchContainment of BiohazardsVirologyCOVID-19HumansUnited StatesVirusesbiosafetyCOVID-19emergenceoversightSARS-CoV-2virology

Identifiers

PMID38168672
PMCPMC10804978
OpenAlexW4390545294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.